CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 136 enrolled
Drug / intervention
Lactate-containing vaginal lubricant +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00981305
NCT00981305Phase 3Completed
CompareCT.gov

Impact of Lactate-containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors: Prospective Randomized Controlled Trial

Seoul National University Hospital·interventional·Posted Sep 22, 2009·Updated Aug 7, 2017

In Brief

A Phase 3 clinical trial evaluating Lactate-containing vaginal lubricant and Placebo vaginal lubricant for Sexual Dysfunction and Breast Cancer Survivors. Completed, enrolled 136 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether lactate-containing vaginal lubricant is effective in the treatment of young breast cancer survivors with sexual dysfunction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSexual Dysfunction, Breast Cancer Survivors
CountriesSouth Korea
CollaboratorsMedical Research Collaborating Center, Seoul, Korea

Timeline

Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 22, 2009
Enrollment StartSep 1, 2009
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 16.8 years ago

Interventions

Lactate-containing vaginal lubricantdrug

vaginal applying at least 3cc of lactate-containing lubricant at the time of sexual intercourse or before sleeping for 8 weeks (at least 3 times/week)

Placebo vaginal lubricantdrug

vaginal applying at least 3cc of placebo lubricant at the time of sexual intercourse or before sleeping for 8 weeks (at least 3 times/week)